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Abstract
The odorous steroid compound 4,16-androstadien-3-one (androstadienone), found in axillary sweat, was previously
reported to evoke hypothalamic activation in heterosexual women, but not in heterosexual men. However, subjects were
exposed to the pure crystalline form of androstadienone, which raised the question whether the observed hypothalamic
response is physiologically relevant. Therefore, in the present study, we asked whether sexually dimorphic hypothalamic
responses could be measured when subjects were exposed to lower, more physiologically relevant concentrations of
androstadienone. A total of 21 women and 16 men, all heterosexual, participated in our functional magnetic resonance
imaging study (fMRI). Three different concentrations of androstadienone diluted in propylene glycol (10 mM ‘‘high,’’ 0.1 mM
‘‘medium’’ and 0.001 mM ‘‘low’’) were delivered to the subjects’ nostrils using a computer-controlled stimulator. When
exposed to the ‘‘high’’ androstadienone concentration, women showed stronger hypothalamic activation than men. By
contrast, men showed more hypothalamic activation when exposed to the ‘‘medium’’ androstadienone concentrations in
comparison to women. Thus, we replicated that smelling the chemo-signal androstadienone elicits a hypothalamic
activation. However, this effect does not seem to be gender-specific, because androstadienone activated the hypothalamus
in both men and women, suggesting that androstadienone exerts specific effects in heterosexual individuals of both sexes.
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Introduction
The importance of olfaction and social chemo-signaling in the
animal kingdom is well established [1]. By contrast, the existence
of chemosensory communication in humans is only beginning to
be accepted. Lundstro¨m et al. [2], [3] showed that humans are
able to distinguish a friend from a close relative or from a stranger,
just by smelling their body odors. Furthermore, human infants,
like other mammalian neonates, are attracted to odor signals
secreted by the mother’s nipple and surrounding areola [4]. Both
examples suggest that body odors are important in social
interactions. One potential candidate for chemo-signaling in
humans is the androgenic steroid 4,16-androstadien-3-one, which
is found in axillary sweat [5], [6]. Several studies have suggested
that androstadienone is processed in a sexually dimorphic way [7-
10]. It has also been demonstrated that androstadienone may have
gender-specific effects on the autonomic nervous system, increas-
ing skin conductance and decreasing skin temperature in women
only [11], [12]. In addition, androstadienone was found to
enhance positive mood in women [7], [9], [13], [14] as well as
stimulate their state of arousal, sense of being focused, and
attention for socio-emotional stimuli [12], [15], [16]. Bensafi et al.
[7] tested for compound concentration effects in their study on the
effects of androstadienone on mood and the autonomic nervous
system. Interestingly, they showed that the effects of androstadie-
none were only observed when androstadienone was applied in
high, not physiologically relevant concentrations (6.25 mM),
whereas no detectable psychological or physiological changes
were apparent when androstadienone was applied in lower
concentrations (0.25 mM). The absolute detection threshold for
androstadienone has been reported to be 0.211 mM [17].
Studies by Savic and coworkers [18-20] suggested that central
processing of androstadienone is sexually dimorphic, as well as
specific to sexual orientation: heterosexual women and homosex-
ual men both showed hypothalamic activation when exposed to
androstadienone, which was contrasted against room air as a
baseline condition. However, heterosexual men and lesbian
women only showed activation in brain areas related to odor
processing, such as the amygdala, piriform cortex, insula and
orbito-frontal cortex. Savic et al. thus proposed that androstadie-
none may be a ‘‘putative male pheromone’’ [21] important in
sexual attraction. However, these authors did not include any
control odor, so that neural activation to androstadienone relative
to a ‘‘higher level’’ could not be assessed. Moreover, subjects were
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exposed to the pure crystalline form of androstadienone, which
raises the question whether the observed hypothalamic response is
physiologically relevant, since the concentration of androstadie-
none excreted in sweat is so much lower [6]. Therefore, in the
present study we used functional magnetic resonance imaging
(fMRI) to investigate whether sexually dimorphic hypothalamic
responses could be observed when subjects were exposed to lower,
more physiologically relevant concentrations of androstadienone.
Materials and Methods
Subjects
The initial study sample consisted of 60 subjects. They were first
tested for their ability to smell androstadienone in order to be able
to participate in the fMRI study. We excluded 21 subjects because
of anosmia to androstadienone. From the 39 remaining subjects,
one did not show up for his fMRI scan and one subject was
excluded from further analysis after she reported having a bisexual
orientation. One of our inclusion criteria was having a heterosex-
ual orientation which was assessed by means of self-report. Thus,
finally, a total of 21 women (mean age = 24.7, SEM =1.4 years)
and 16 men (mean age = 24.7, SEM =1.1 years) participated in
the fMRI study. They were all right-handed, heterosexual
volunteers and were not using any medication. Females used no
oral contraceptives and all had regular menstrual cycles. Normal
olfactory function of the participants was ascertained by means of
the ‘‘Sniffin’ Sticks’’ test battery [22]. An estimation of the
detection threshold for androstadienone (Steraloids Inc., Newport,
RI, USA) was obtained for each participant with a three-
alternative forced-choice detection test consisting of six concen-
trations of androstadienone dissolved in propylene glycol (10 mM,
1 mM, 0.1 mM, 0.001 mM, 0.0001 mM, 0.00001 mM), with one
of the three glass jars containing androstadienone and the other
two the solvent, propylene glycol (Fluka, Sigma-Aldrich Chemie
Gmbh, Munich, Germany). The three glass jars, containing 10 ml
of liquid each, were presented in ascending order until subjects
had correctly identified androstadienone in two consecutive trials,
which was then used as an estimation of the detection threshold for
this participant. During the screening session, subjects were asked
to report the intensity (on a scale from 0 to 10) and quality of the
10 mM, ‘‘high’’ concentration (on a scale from 25 to +5).
MRI sessions were planned a few days after the day of
screening. Participants were asked not to wear any perfume on the
day of scanning and not to eat or drink anything other than water
one hour before scanning. Subjects were instructed to breathe
through their mouths during the odor stimulations and females
were scanned during the second or third week of their menstrual
cycle, which was determined by means of self-report. Subjects gave
their informed consent, according to the Declaration of Helsinki,
and the study was approved by the Ethics Committee of the
Medical Faculty, University of Dresden (application number
EK373122009).
Delivery of Olfactory Stimuli
Subjects were exposed to two different olfactory stimuli during
the scanning sessions: 1) androstadienone and 2) 1-butanol (Merck
Chemicals, Darmstadt, Germany). Androstadienone, which were
diluted in propylene glycol to three different concentrations:
10 mM ‘‘high,’’ 0.1 mM ‘‘medium’’ and 0.001 mM ‘‘low,’’ was
used to determine whether there would be gender-specific effects
in hypothalamic activation as well as whether there would be any
dose-dependent effects of the steroid on hypothalamic activation.
The medium concentration was based on the mean detection
threshold for androstadienone. Butanol was diluted in propylene
glycol to a concentration of 0.01 mM and was used as a control
odor. The volume of each solution used during the fMRI
experiments was 20 ml. Olfactory stimuli were delivered through
a tubing system to the subjects’ nostrils by means of an air-dilution
olfactometer [23]. Briefly, in the olfactometer setup used in our
study, air is obtained from a regular clean air outlet in the wall and
directed via computer-controlled electro-pneumatic valves to 5
gas-washing bottles, which contain the liquid odorants (in our case:
androstadienone in three different concentrations) and the control
fluids (butanol and water). When the air enters the olfactometer, a
constant airflow is achieved by using a ball-flow-meter, The air is
then directed into a solenoid operated three-way pneumatic
switching valve. In its turned-off-state, the air leaves the valve
through the port which functions as an exhaust and maintains a
steady airflow. When the airflow-valve is turned on, the air leaves
this valve passing the normally open port, which is split into 5
connections. This separates the air into 5 streams and distributes it
over five solenoid operated three-way pneumatic switching valves.
The air is saturated with odorant as it travels through the porous
frit at the bottom of the gas-washing bottles and forms small air-
bubbles. Upon exiting the 5 gas washing chambers, the odorized
or control air passes through 5 individual Teflon tubes to the
delivery section. Just before entry into the subject’s nose, the gas-
flow is reunited using t-fittings into a single flow line inside a 5 cm
Teflon hose. The olfactometer uses a continuous airflow design
and as a result, regardless of how many valves are simultaneously
opened, the resulting airflow at the delivery unit always matches
the one entering the device avoiding air-puffs at the outlet. With a
total air flow of 2 L per minute, during ‘‘ON’’ periods every 2
seconds odors where delivered during 1 second, while during
‘‘OFF’’ periods subjects received odorless air. The presentation
order of odors (3 6 androstadienone, 1 6 butanol) was
randomized across subjects. After each odor session, subjects were
asked to report intensity and valence of the three different
androstadienone concentrations and the control odor butanol on a
10-point scale.
fMRI Protocol
Scans were performed on a 1.5 Tesla scanner (Siemens
Magnetom SONATA; Siemens Healthcare, Erlangen, Germany).
A gradient echo (GE) echoplanar imaging (EPI) sequence was used
for functional imaging. The parameters included a 10615 cm2
field of view, TR of 2240 msec, TE of 40 msec, a 90u flip angle, 27
slices, voxel resolution of 2.362.363 mm. The scanning volume
was centered on the hypothalamus. Before each imaging session
an automated local shimming technique was used to reduce
susceptibility artifacts. A scanning session consisted of four
subsessions, during each of which 108 images were acquired,
lasting 4.06 min. Each odor session consisted of 6 alternating
‘‘ON-OFF’’ cycles over 108 scans in a classical block design. For
Table 1. Androstadienone threshold estimations during the
screening session.
Total (in %) Females (n=21)/Males (n =16)
10 mM 10.5 1/3
1 mM 15.8 5/1
0.1 mM 47.4 9/8
0.01 mM 23.7 6/3
0.001 mM 2.6 0/1
doi:10.1371/journal.pone.0040993.t001
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co-registration with the functional images a T1-weighted scan was
obtained (3D IR/GR sequence, TR=2180 ms, TE= 3.93 ms).
fMRI Data Analysis
fMRI data were analyzed using SPM8 (Wellcome Trust Centre
for Neuroimaging, http://www.fil.ion.ucl.ac.uk/spm). Functional
images were realigned to the mean image, co-registered with the
individual T1 scan and normalized to MNI (Montreal Neurolog-
ical Institute) space using segmentation. Finally, images were
spatially smoothed with a 4 mm full width half maximum
(FWHM) isotropic Gaussian kernel. This setting was chosen not
to exceed the size of the anatomical structure of interest, the
hypothalamus. In order to identify the effect of odor stimulation,
first level linear contrast images were entered into a general linear
model (GLM), generating statistical images. These images
displayed the effect of odor stimulation (‘‘On’’ blocks versus
‘‘Off’’ blocks) in each participant. Next, these contrast images were
entered into second-level group analyses to investigate the effects
of group (men versus women) and odor concentration.
In order to address the main questions of the study, i.e. whether
there are any sex differences in hypothalamic activation upon
smelling androstadienone, and whether the hypothalamus would
respond differently in the two sexes to the three androstadienone
concentrations, a flexible factorial model was applied. The factors
‘‘gender,’’ having two levels (females and males) and ‘‘androstadie-
none,’’ having three levels (three different concentrations) were
defined, as well as the factor ‘‘subject’’ (accounting for multiple
within-subject observations), in order to investigate the interaction
effects of gender and concentration. Furthermore, to correct for
subjective differences in perceived odor concentrations, the
behavioral variable of subjective ratings of odor intensity, obtained
after each odor session, was included as a covariate in the flexible
factorial model. Sex differences for each of the three androstadie-
none concentrations were analyzed separately using two-sample t-
tests.
We defined a hypothalamic region of interest (with Marsbar,
[24]) by modeling brain activation across all subjects and
androstadienone concentrations, and built a region of interest
for the cluster of hypothalamic activation (peak voxel MNI-
coordinates: x = 2, y =26, z = 0; volume size = 250 mm3). This
region of interest was applied at the second level to investigate
differences between groups and concentrations. For illustrative
purposes we extracted contrast values for each concentration
condition of androstadienone, using this hypothalamic region of
interest. It was ensured that the reported cluster fell within
coordinates defined as pertaining to the hypothalamus in earlier
studies [19], [20], [25-29]. The statistical threshold was set at
p,0.05, using family-wise error (FWE) correction for multiple
comparisons in small volumes.
Additionally, we investigated a set of predefined olfactory regions
of interest for possible sex differences in activation, i.e. amygdala,
piriform cortex, insula, the orbito-frontal cortex (OFC) and the
anterior cingulate cortex (ACC) since it has been suggested that these
brain areas are implicated in the processing of androstadienone [20],
[30]. For these analyses, the dataset was smoothed differently,
applying a kernel of 6 mm. This setting was chosen in order to
increase the signal-to-noise ratio and to account for the larger
anatomical variability in cortical brain regions, compared to the
(much) smaller hypothalamus.The anatomical borders for each area
of interest were defined by using overlays generated by the Wake
Forest University (WFU) Pickatlas [31] toolbox for SPM. Applying
these regions of interest asmask images, the data were analyzed with
respect to the effects of each odor (androstadienone and butanol) and
for sex differences in response to smelling androstadienone (across
concentrations) or butanol. The statistical threshold was set at
p,0.05 (FWE corrected).
Table 2. Intensity ratings during screening and scan sessions on a scale from 0 to 10.
Females (n=21) Males (n=16)
Mean St.dev. Mean St.dev. T-value P-value (sex difference)
Screening 6.9 2.3 6.4 2.2 0.64 0.526
AND high 4.9 2.7 3.9 2.5 1.08 0.289
AND medium 4.6 2.7 4.3 1.9 0.39 0.700
AND low 2.7 2.9 3.9 2.9 21.27 0.214
Butanol 5.9 2.9 5.0 2.1 1.02 0.317
AND= androstadienone; St.dev. = standard deviation.
doi:10.1371/journal.pone.0040993.t002
Table 3. Valence ratings during screening and scan sessions on a scale from 25 to +5.
Females (n =21) Males (n=16)
Mean St.dev. Mean St.dev. T-value P-value (sex difference)
Screening 21.2 2.6 22.0 1.6 1.04 0.307
AND high 20.3 1.6 20.9 1.3 1.24 0.224
AND medium 21.1 1.6 20.5 1.6 21.05 0.302
AND low 20.3 1.6 21.1 1.7 1.47 0.152
Butanol 21.0 2.1 21.0 1.8 0.00 1.000
AND= androstadienone; St.dev. = standard deviation.
doi:10.1371/journal.pone.0040993.t003
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Results
Hedonic & Intensity Ratings
During the screening session, detection thresholds for andros-
tadienone were estimated in all participants (Table 1) as well as
their overall olfactory function by means of the Sniffin’ Sticks test
battery. After each fMRI odor session the intensity and valence of
the three different androstadienone concentrations and the control
odor butanol were rated on a 10-point scale by the participants.
There were no differences in the intensity and hedonic ratings
between men and women on any of these measurements.
However, overall, intensity ratings obtained during the screening
session (concentration of androstadienone used: 10 mM) differed
significantly (t =23.9; df = 36; p,0.0001) from the intensity
ratings obtained during scanning sessions of the high concentra-
tion of androstadienone (10 mM). Furthermore, men rated the
three concentrations during the scanning sessions as evenly
intense, so they did not perceive any differences between the
three concentrations in the MRI (see Table 2 & 3).
Sex & Concentration Effects – Hypothalamus
In order to determine whether the hypothalamus was respond-
ing differentially in men and women to the three concentrations of
androstadienone, a flexible factorial model was applied. There was
a significant interaction effect between group (men or women) and
androstadienone concentration condition (F= 15.4, p,0.001;
MNI-coordinates: x = 2; y =26; z = 0), indicating that men and
women show differential activation of the hypothalamus, depend-
ing on the androstadienone concentration they were exposed to
during the scanning (see Figure 1). To determine whether this
hypothalamic activation was modulated by subjects’ perception of
the odor concentrations, intensity ratings obtained per session
were added as a covariate to the model. This had no effect on the
overall results.
Next, the direction (female . male or male . female) of this sex
difference in the hypothalamus was tested separately for the three
different androstadienone concentrations. Statistical analyses using
two-sample t-tests revealed that when smelling the ‘‘high’’
androstadienone concentration women showed a more significant
hypothalamic activation in comparison to men (T= 3.39,
p = 0.013; FWE-corrected), which is in line with previous studies
[20]. In contrast, when smelling the ‘‘medium’’ concentration,
men showed a stronger hypothalamic activation than women
(T= 3.96, p = 0.003; FWE-corrected). Using one-sample t-tests,
males and females were also investigated separately. However,
only one effect, males smelling the ‘‘medium’’ androstadienone
concentration, survived the statistical threshold of p,0.05
(T= 4.30, p = 0.001; FWE-corrected) (see Figure 2 & Table 4).
Figure 3 depicts the beta values for the sex differences across the
three androstadienone concentrations.
Androstadienone Versus Butanol
The contrast ‘‘androstadienone versus baseline’’ over the total
sample indicated significant activations in all our olfaction-related
regions of interest, except for the ACC and the piriform cortex.
Contrasting ‘‘butanol versus baseline’’ yielded significant clusters
in the amygdala, insula, the OFC, and a near-significant cluster in
the piriform cortex. No significant activation could be found in the
ACC and the hypothalamus. When contrasting both odors against
each other, no activation in any of the regions of interest survived
the statistical threshold of p,0.05, FWE-corrected (see Table 5).
Figure 1. Hypothalamus activation for the interaction effect of the factors ‘‘group’’ and ‘‘androstadienone concentration’’. F-
contrast, testing for group (men and women) differences in hypothalamus activation, dependent on androstadienone concentration condition. The
color bar depicts the F statistic and image coordinates (x = 2; y =26; z = 0) are in Montreal Neurological Institute brain atlas space.
doi:10.1371/journal.pone.0040993.g001
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Figure 2. Sex differences in hypothalamus activation. (A) Hypothalamus activation in women, compared to men (directional t-contrast), who
were exposed to the high concentration of androstadienone. (B) Hypothalamus activation in men, compared to women (directional t-contrast), who
were exposed to the medium concentration of androstadienone. The color bar depicts the t statistic and image coordinates (x = 2; y =26; z = 0) are in
Montreal Neurological Institute brain atlas space.
doi:10.1371/journal.pone.0040993.g002
Hypothalamic Responses to Androstadienone
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Finally, we explored whether other olfactory brain regions, i.e.
insula, amygdala, piriform cortex, OFC and ACC would show sex
differences in activation as well. When exposed to androstadie-
none, regardless of concentration, none of our olfactory regions of
interest showed any sex differences in activation. Also, no sexually
dimorphic activation was found for the contrast ‘‘butanol versus
baseline’’.
Discussion
In contrast to previous studies [20], the present study, using
fMRI, showed hypothalamic activation in both men and women
when exposed to androstadienone. However, sex differences were
observed related to the three different concentrations of andros-
tadienone used in the present study. When smelling the high
concentration, women showed significantly more hypothalamic
activation than men. By contrast, men compared to women,
showed significantly stronger hypothalamic activation when
smelling the medium concentration of androstadienone. Our
results thus confirm that smelling androstadienone produces
physiological effects in the hypothalamus in both sexes, but the
direction of the sex difference depends on the concentration of
androstadienone.
The female response to the high concentration of androstadie-
none is partially in line with the observations of Savic et al. [20]
who reported that only women but not men showed hypothalamic
activation when exposed to androstadienone. However, it is
difficult to compare our results directly to those of Savic et al. [18],
due to differences in experimental design such as odor delivery as
well as applied imaging technique. In their study, 200 mg of
androstadienone in crystallized, pure form was presented to the
subject’s nose while being scanned using positron emission
tomography. By contrast, we used an olfactometer to deliver
various concentrations of androstadienone intranasally. We
assume that the concentration used by Savic et al. [18] was
considerably higher than our ‘‘high’’ condition, which is still much
higher than what would occur naturally [5], [6]. Our ‘‘low’’
(0.001 mM) condition of androstadienone more closely approach-
es naturally occurring concentrations and may thus represent the
most physiologically relevant condition tested here. We observed
hypothalamic activation with the low concentration (see Table 4),
even though only one subject was actually able to consciously
detect this concentration, suggesting that androstadienone is
processed without any conscious awareness of the odor.
In women, it has been shown that exposure to axillary male
sweat accelerated pulses of luteinizing hormone [32], suggesting
that such axillary excretions, which include androstadienone,
induce neuroendocrine changes that are important for reproduc-
tion. Ferdenzi et al. [33] reported that the perceived intensity of
body odors (axillary male sweat) by female raters was positively
correlated with judging these odors as being more masculine. The
Table 4. One-sample and two-sample t-tests, with directional
t-contrasts testing for sex differences in the hypothalamus,
separately for the three different androstadienone
concentration conditions.
T-value
P-value
(uncorrected)
P-value
(FWE-
corrected)
MNI
coordinates
XYZ
Females
AND high 2.31 0.013 0.106 2 26 0
AND medium 1.25 0.103 0.385 4 26 24
AND low 1.30 0.097 0.372 2 28 22
Females . Males
AND high 3.39 0.001 0.013* 2 26 0
AND medium 21.46 0.603 0.676 4 26 24
AND low 1.73 0.045 0.240 2 28 22
Males
AND high 20.28 0.456 0.674 4 28 22
AND medium 4.30 0.000 0.001* 4 26 22
AND low 2.44 0.010 0.085 2 24 22
Males . Females
AND high 21.31 0.594 0.681 4 28 0
AND medium 3.96 0.000 0.003* 2 26 0
AND low 2.26 0.015 0.115 2 24 0
AND= androstadienone; FWE = family-wise error; * = statistically significant at
p,0.05; coordinates are in Montreal Neurological Institute (MNI) brain atlas
space.
doi:10.1371/journal.pone.0040993.t004
Figure 3. Contrast values for the three different androstadienone concentrations. Contrast values were extracted from the hypothalamus
(region of interest at MNI coordinates x = 2; y =26; z = 0, sphere diameter of 8 mm). Contrast values were determined for each of the three
androstadienone concentration conditions and depicted separately for men and women. Error bars reflect the 95% confidence interval.
doi:10.1371/journal.pone.0040993.g003
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stronger an odor, the more likely the odor was judged to be of
masculine origin [34]. Furthermore, Hummel et al. [35] found
that women’s hedonic ratings of androstenone varied across the
menstrual cycle, peaking at ovulation. Because women are
especially sensitive to strong, masculine chemo-signals around
ovulation, hypothalamic activation in response to androstadienone
may reflect an increase in sexual motivation [36] since our female
subjects were all tested around ovulation, when endogenous
estrogen levels are high. However, in the present study, we found
that men also showed hypothalamic responses to androstadienone.
This result is surprising in view of the claim that androstadienone
may be a ‘‘putative male pheromone,’’ which was based on the
finding that heterosexual women and homosexual men, but not
heterosexual men and lesbian women, showed hypothalamic
activation to androstadienone [18], [19]. However, animal studies
[37] have shown that both male and female mice showed neural
activation in main olfactory bulb mitral cells that project to the
medial amygdala after exposure to male urinary odors, suggesting
that male odors are also salient to males, perhaps related to
territoriality in this species. Why would men show hypothalamic
activation when smelling androstadienone? It is possible that the
hypothalamic response to androstadienone reflects a general
increase in drive, arousal and motivation rather than being
specific to sexual behavior and motivation [38]. However, our
observation of hypothalamic responses to androstadienone in
heterosexual men points to a need for a more thorough analysis of
possible behavioral and/or physiological actions of this compound
Table 5. Main effect analyses for the two odors androstadienone and butanol with one-sample t-tests investigating whole group
brain activations in predefined olfactory regions of interest.
L/R T-value
P-value
(uncorrected)
P-value
(FWE-corrected)
MNI coordinates
x y z
Androstadienone vs baseline
ACC L
R
2.68
2.97
0.006
0.003
0.705
0.488
26 28 30
14 26 24
Amygdala L
R
R
4.82
2.62
1.49
0.000
0.006
0.070
0.002*
0.238
0.700
228 2 222
30 4 220
24 28 212
Hypothalamus R 3.88 0.000 0.002* 4 26 0
Insula L
R
4.39
3.40
0.000
0.001
0.043*
0.329
240 8 210
40 24 4
OFC L
R
R
5.07
4.20
2.47
0.000
0.000
0.009
0.009*
0.113
0.980
234 30 26
44 30 210
16 56 28
Piriform Cortex L
R
2.41
3.06
0.011
0.002
0.378
0.127
222 4 218
30 10 220
Butanol versus baseline
ACC L
R
3.03
2.43
0.002
0.010
0.475
0.794
210 34 24
2 32 24
Amygdala L
R
4.19
3.85
0.000
0.000
0.009*
0.021*
218 24 218
28 24 218
Hypothalamus R 1.04 0.142 0.362 4 26 24
Insula L
R
4.97
4.45
0.000
0.000
0.010*
0.036*
242 18 22
26 22 218
OFC L
R
4.73
5.75
0.000
0.000
0.025*
0.001*
244 18 22
24 22 218
Piriform Cortex L
R
1.93
3.27
0.030
0.001
0.617
0.072
226 6 218
26 8 218
Androstadienone versus Butanol
ACC L
L
R
2.52
2.47
2.93
0.008
0.009
0.003
0.775
0.803
0.498
28 2 30
212 36 28
14 28 22
Amygdala L
R
1.60
1.22
0.057
0.109
0.614
0.761
220 2 220
26 6 16
Hypothalamus L 0.76 0.203 0.439 22 26 2
Insula L
R
3.45
3.05
0.001
0.002
0.298
0.531
232 0 12
38 20 28
OFC L
R
2.89
3.03
0.003
0.002
0.842
0.778
218 50 210
20 58 24
Piriform Cortex L
R
1.69
2.34
0.049
0.013
0.717
0.410
220 6 218
26 10 216
* = statistically significant at p,0.05; FWE = family-wise error; L = left; R = right; ACC = anterior cingulate cortex; OFC = orbito-frontal cortex; coordinates are in
Montreal Neurological Institute (MNI) brain atlas space.
doi:10.1371/journal.pone.0040993.t005
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in heterosexual men, either in the context of male-male or of male-
female interactions.
Savic and coworkers [18] also showed that only brain areas
related to odor processing, such as the piriform cortex and the
amygdala, were activated in heterosexual men when smelling
androstadienone. Female subjects, by contrast, showed no brain
activation, other than the hypothalamic response when smelling
androstadienone. We also investigated whether other olfactory
regions were affected when exposed to androstadienone (see
Table 5). In our study, both andostadienone and butanol
(implemented as a non-social odor) activated the expected
olfactory processing-related areas, such as the orbitofrontal cortex,
insula and amygdala. It has been suggested [9], [13], [15], [39],
that the steroid odor androstadienone may have neuromodulatory
effects on central processes related to alertness, attention, and
mood. The study by Hummer & McClintock [13] in which 50
men and women were tested in three psychological experiments,
showed that androstadienone significantly enhanced attention to
emotional information, but these effects were found in both sexes.
Thus, brain areas other than the primary olfactory brain regions
may be involved in the processing of androstadienone. Jacob et al.
[30] acquired positron emission tomography scans in 10 women
while smelling androstadienone, and, apart from the hypothala-
mus, observed changes in glucose utilization in several regions
involved in mood regulation such as the amygdala and the ACC.
However, since no men were included in that study, no
information is available on sex-related differences. In the present
study, when investigating sex differences in response to smelling
androstadienone, regardless of concentration, activation in our
olfactory regions of interest did not survive the statistical threshold
set at 0.05, FWE-corrected. Therefore, in contrast to the study by
Savic et al. [18], the hypothalamus was the only region showing a
sexually dimorphic response to androstadienone.
The reported intensity of androstadienone during the screening
session compared to the scanning session differed significantly,
even though the presented concentration was the same for both
situations (10 mM). Furthermore, intensity ratings of the three
different concentration conditions during scanning were not
proportional to the actual concentrations, e.g. men rated the low
concentration as evenly intense as the high concentration of
androstadienone. One reason for these discrepancies might simply
be the different environment and conditions under which the
ratings had to be made. It has been shown that a supine body
position (like in an MRI scanner) in comparison to an upright
body position may influence sensitivity to odors [40-42].
A study by Jacob et al. [13] has shown that effects of
androstadienone might extend beyond immediate stimulation,
thus having longer-lasting pharmacological-like effects on the
organism. We cannot rule out that randomizing the different odor
conditions might have had some confounding effects on brain
activation or odor perception. Future studies should attempt to
optimize the experimental fMRI setup to capture the cerebral
activation related to processing social chemo-signals such as
androstadienone.
Conclusion
In summary, both men and women showed a hypothalamic
activation upon smelling androstadienone. Thus, we were not able
to replicate the earlier reported gender-specific hypothalamic
activation by androstadienone. Some sex differences were
observed with the three different concentrations of androstadie-
none used in the present study. However, the physiological
relevance of these concentration-related effects remains unclear. In
particular, our finding of hypothalamic responses to our ‘‘medi-
um’’ concentration of androstadienone in heterosexual men points
to a need for a more thorough analysis of possible behavioral and/
or physiological actions of this compound in heterosexual men,
either in the context of male-male or of male-female interactions.
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